InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+9.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Hall Brett Matthew, Directeur Scientifique. Officer active across 1 company, notably Immuneering Corp. Cumulatively, 8 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €43k. Activity tracked since 23 March 2022. The latest transaction was disclosed on 15 January 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hall Brett Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,298 shares@ US$4.5712.8% of flowClass A Common StockSEC:0001790340-26-000012:0
Canonical exit: 15 Apr 2026 (T+90)
14,880 shares@ US$1.42829.3% of flowClass A Common StockSEC:0001790340-25-000111:0
7,415 shares@ US$2.699940.0% of flowClass A Common StockSEC:0001790340-25-000087:0
Canonical exit: 18 Sept 2025 (T+90)
6,211 shares@ US$1.6235.4% of flowClass A Common StockSEC:0001790340-24-000034:0
2,551 shares@ US$3.9213.3% of flowClass A Common StockSEC:0001415889-22-005796:0
Canonical exit: 23 Aug 2022 (T+90)
1,050 shares@ US$7.9110.7% of flowClass A Common StockSEC:0001415889-22-003305:0
Canonical exit: 21 Jun 2022 (T+90)
322,691 sharesClass A Common StockSEC:0001415889-21-006188:0
5,040 sharesClass A Common StockSEC:0001104659-21-099733:0
8 of 8 declarations
About Hall Brett Matthew
Hall Brett Matthew is Director Scientifique and CHIEF SCIENTIFIC OFFICER at Immuneering Corp (XNAS). He has 8 filings in total, and across the 8 sampled filings the buy amount is EUR 43294, with no sells; the period covered runs from 2021-08-04 to 2026-01-16.
